SCHEMBL13675152

SCHEMBL13675152

CCc1cc(-c2cc[nH]n2)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.47
ESR1 P03372 5/20 0.41
ESR2 Q92731 5/20 0.41
AR P10275 1/20 0.40
BACE1 P56817 1/20 0.39
HSP90AA1 P07900 2/20 0.37
HSP90AB1 P08238 2/20 0.37
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B2 P37059 1/20 0.36
ALOX5 P09917 1/20 0.36
DAO P14920 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
CA12 O43570 1/20 0.34
ALPL P05186 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4096433 0.94 HSD17B1 (0.53) HSD17B1ESR1ESR2ARBACE1
SCHEMBL13675229 0.81 MAPK1 (0.35) ESR1ESR2CA12ALPLCA9
SCHEMBL1924473 0.79 APP (0.50) ESR2HSP90AA1HSP90AB1MEN1GAA
SCHEMBL13675220 0.78 SRD5A2 (0.40) MEN1KMT2AGABRA1GABRB2ALPL
SCHEMBL19368353 0.77 ESR1 (0.37) ESR1ESR2CA12ALPLCA9
SCHEMBL28818892 0.77 CA12 (0.56) GAAKMT2ACA12ALPLCA9
SCHEMBL3953461 0.76 HSD17B1 (0.71) HSD17B1ESR1ESR2ARBACE1
SCHEMBL15889935 0.76 PDE4A (0.47) MEN1GAAKMT2A
SCHEMBL10200379 0.75 APP (0.34) ESR2MEN1GAAKMT2AALOX5
SCHEMBL16627909 0.75 ESR2 (0.47) HSD17B1ESR1ESR2ARHSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors CORBETT JEFFREY WAYNE 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, PC, ACACB HSD17B1 219/4885ESR1 2656/4885ESR2 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.